Form 4 for CRNC Cerence Inc.
Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-13 · accession 0000950170-25-005899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 2025-01-13 | CRNC | Schanz Nils | EVP Product, Technology | A - Grant | $13.76 | +93.7K | 145.3K | +182% | +$1.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-13 | A | A | 93,720 | $13.76 | 145,289 | D | — | — | (F1) Grant of Restricted Stock Units subject to the Restricted Stock Unit Agreement. Shares vest one-third on each of October 1, 2025, 2026, and 2027. |